# US 2017/0281698 A1 · Method and Composition for Inhibiting Bacterial Adhesion of Oral Pathogens

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281698 A1
- Document ID: US20170281698A1
- Status: Published application
- Kind: A1
- Application number: 15/176,773
- Filed: 2016-06-08
- Published: 2017-10-05
- Earliest claimed: 2016-04-01
- Assignees: GenMont Biotech Inc.
- Applicants: Genmont Biotech Inc.
- Inventors: Yi-Hsing Chen; Ya-Hui CHEN; Chien-Chen WU
- Web page: https://patentgrep.com/patent/US20170281698A1

## CPC

- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A61K 8/99: from microorganisms other than algae or fungi, e.g. protozoa or bacteria
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/0063: {Periodont}
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 31/02: Local antiseptics
- A61P 31/04: Antibacterial agents
- A61Q 11/00: Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

A method for inhibiting bacterial adhesion of oral pathogens, comprising administering a heat-inactivated Lactobacillus strain to a subject in need to inhibit bacterial adhesion of oral pathogens is disclosed. The Lactobacillus strain is selected from Lactobacillus paracasei GMNL-143, Lactobacillus helveticus GMNL-164 or Lactobacillus rhamnosus GMNL-464. A composition for inhibiting bacterial adhesion of oral pathogens is also disclosed.

## Claims

### Claim 1

A method for inhibiting bacterial adhesion of oral pathogens, comprising administering a heat-inactivated Lactobacillus strain to a subject in need to inhibit bacterial adhesion of oral pathogens, wherein the Lactobacillus strain is selected from Lactobacillus paracasei GMNL-143, Lactobacillus helveticus GMNL-164 or Lactobacillus rhamnosus GMNL-464, wherein the Lactobacillus paracasei GMNL-143 is deposited at CGMCC-China General Microbiological Culture Collection with deposit number CCTCC No. M2014301, wherein the Lactobacillus helveticus GMNL-164 is deposited at CGMCC-China General Microbiological Culture Collection with deposit number CCTCC No. M2015609, wherein the Lactobacillus rhamnosus GMNL-464 is deposited at CGMCC-China General Microbiological Culture Collection with deposit number CCTCC No. M2015610, wherein the Lactobacillus strain is heat-inactivated at 90-121° C. for 15-30 minutes.

### Claim 2 (depends on 1)

The method for inhibiting bacterial adhesion of oral pathogens according to claim 1, wherein the Lactobacillus strain is orally administered to the subject in need at dosage of 3×108-1×1010 cells/time.

### Claim 3

A composition for inhibiting bacterial adhesion of oral pathogens, comprising:
a heat-inactivated Lactobacillus strain selected from a group consisting of Lactobacillus paracasei GMNL-143, Lactobacillus helveticus GMNL-164 and Lactobacillus rhamnosus GMNL-464, wherein the Lactobacillus paracasei GMNL-143 is deposited at CGMCC-China General Microbiological Culture Collection with deposit number CCTCC No. M2014301, wherein the Lactobacillus helveticus GMNL-164 is deposited at CGMCC-China General Microbiological Culture Collection with deposit number CCTCC No. M2015609, wherein the Lactobacillus rhamnosus GMNL-464 is deposited at CGMCC-China General Microbiological Culture Collection with deposit number CCTCC No. M2015610, wherein the Lactobacillus strain is heat-inactivated at 90-121° C. for 15-30 minutes; and
a medical acceptable excipient.

### Claim 4 (depends on 3)

The composition for inhibiting bacterial adhesion of oral pathogens according to claim 3, wherein the composition comprises the Lactobacillus paracasei GMNL-143, the Lactobacillus helveticus GMNL-164 and the Lactobacillus rhamnosus GMNL-464 in the ratio 1:1:1.
